Epilepsy affects 70M people worldwide. Seizures particularly those with loss of consciousness are difficult to identify and more likely to result in injury. Detecting and responding to seizures is critical to managing epilepsy but today’s solutions are insufficient. Eysz is developing a software-based digital therapeutic built on patented eye-tracking technology to identify seizures, track side effects, and respond to medications in real time. Our solution will also allow researchers, medical device companies, and pharmaceutical companies to accelerate new therapies by enabling faster, cheaper, and more effective clinical studies…all to improve the quality of life for patients with epilepsy.